drugset / Trial / NCT06942000

Intrathecal DEX With Bupivacaine Inpost-spinal Shivering After CS.

NCT06942000

Phase 3 Not yet recruiting 40 enrolled Al-Azhar University
RandomizedParallel-groupDouble-blindPrevention

Summary

This prospective, randomized, double-blind, placebo-controlled study to determine whether intrathecal dexmedetomidine, administered along with hyperbaric bupivacaine for covering Cesarean delivery decreases the incidence of shivering associated with spinal anesthesia

Timeline

Start
2025-05-01
Primary completion
2025-11-30
Completion
2025-12-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 3 ug Intrathecal
Comparator Dexmedetomidine Other / unclassified 5 ug Intrathecal